Risk for Guillain-Barré syndrome up after Ad.26.COV2.S vaccination
Apr 26, 2022
An adjusted rate ratio of 20.56 was found in a head-to-head comparison of the Johnson & Johnson vaccine and the Pfizer-BioNTech and Moderna COVID-19 vaccines.
FDA panel recommends approval of Johnson & Johnson booster shot
Oct 15, 2021
The booster shot is recommended for anyone 18 years and older, to be given at least two months after the first dose.
Mounjaro approved for blood glucose control in type 2 diabetes
May 20, 2022
The once-weekly injection is approved as an addition to diet and exercise.
AI algorithm accurately IDs two life-threatening heart conditions
Mar 14, 2022
The model can distinguish between hypertrophic cardiomyopathy and cardiac amyloidosis using ultrasound videos.
Oral probenecid cuts time to viral clearance in COVID-19
Aug 01, 2023
The median time to viral clearance was significantly shorter for 500 and 1,000 mg probenecid versus placebo.
FDA approves new diet drug Zepbound, a version of the diabetes med Mounjaro
Nov 09, 2023
Zepbound works by activating hormone receptors in the body to reduce appetite and food intake
FDA approves new antibiotic for three indications
Apr 08, 2024
Zevtera is approved for S. aureus bloodstream infections, acute bacterial skin/skin structure infections and bacterial pneumonia.
CDC signs off on Moderna, J&J boosters, backs mix ‘n’ match shots
Oct 22, 2021
The agency plans to release guidance early next week about who might benefit from choosing one booster over another.
Expanded use of Xolair to treat food allergies approved by the FDA
Feb 17, 2024
Xolair is not meant to substitute for emergency anaphylaxis medications such as the EpiPen.
First FDA-approved fecal-based treatment helps fight C. difficile
Dec 01, 2022
Rebyota is prepared from human stool donated by qualified individuals.